VersaTrial Strengthens Advisory Board with Appointment of Noelle Gaskill

WILTON, Connecticut, September 5, 2023 – VersaTrial, the clinical research site enablement and engagement platform, proudly welcomes Noelle Gaskill to its Advisory Board. As a seasoned executive with 25 years of clinical research experience, Gaskill's appointment strengthens VersaTrial's commitment to reducing the burden on research site staff.

Starting her career as a Research Coordinator and Technician, Gaskill has since advanced to hold leadership roles in a variety of organizations spanning biotechnology and life science software. Today, she serves as the Head of Clinical Research Collaborations at Mirati Therapeutics Inc. Her career trajectory, with its balance of hands-on clinical roles and strategic operational leadership, provides Gaskill with a unique understanding of research site challenges and gives her broader insights into clinical research from the perspective of a Sponsor.

"Noelle's breadth and depth of experience strongly align with our mission at VersaTrial. Her track record of deploying initiatives aimed at reducing site burden will be instrumental as we continue to innovate our platform. Together with our esteemed Advisory Board members Allison Kemner, Erin O'Boyle, and Jackie Kent, Noelle will contribute significantly to our strategic vision."

"Noelle's breadth and depth of experience strongly align with our mission at VersaTrial," said Mike Wenger, Founder and CEO of VersaTrial. "Her track record of deploying initiatives aimed at reducing site burden will be instrumental as we continue to innovate our platform. Together with our esteemed Advisory Board members Allison Kemner, Erin O'Boyle, and Jackie Kent, Noelle will contribute significantly to our strategic vision."

"I'm thrilled to be part of VersaTrial. Throughout my career, I've aimed to streamline and improve the effectiveness of clinical research. It feels great to contribute to VersaTrial’s mission of reducing tech burden in order to boost site staff productivity, communication, and job satisfaction."

Gaskill voiced her excitement about joining VersaTrial's Advisory Board, "I'm thrilled to be part of VersaTrial. Throughout my career, I've aimed to streamline and improve the effectiveness of clinical research. It feels great to contribute to VersaTrial’s mission of reducing tech burden in order to boost site staff productivity, communication, and job satisfaction."

About VersaTrial

VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at versatrial.io